NEW YORK (Reuters Health) – A review of available evidence indicates that colchicine given after cardiac surgery reduces the risk of developing post-pericardiotomy syndrome, or PPS. “The data…
NEW YORK (Reuters Health) – Subcutaneous immunotherapy is at least as effective as drug therapy in controlling symptoms of seasonal allergic rhinitis, even in the first season after…
NEW YORK (Reuters Health) – Hysteroscopy using narrow-band imaging (NBI) technology may be more sensitive than white-light imaging (WLI) for diagnosing endometrial cancer and hyperplasia, hint results of…
NEW YORK (Reuters Health) – Patients with hypercholesterolemia who do not reach target lipid levels with rosuvastatin have a better change of reaching their goals by adding ezetimibe…
NEW YORK (Reuters Health) – Results of a Mexican study indicate that 2 months of treatment with the antiinflammatory agent diacerein increases insulin secretion and improves A1C levels…
NEW YORK (Reuters Health) – For patients with acute MI given early unfractionated heparin, a switch to bivalirudin before undergoing primary percutaneous coronary intervention results in improved cardiac…
NEW YORK (Reuters Health) – After chemotherapy-induced remission of follicular lymphoma, vaccination with a patient-specific tumor-derived antigen improves disease-free survival, a multicenter team has shown. Furthermore, the vaccine…
NEW YORK (Reuters Health) – Growth hormone treatment of adults isn’t associated with an increased risk of developing diabetes, according to a new report. “The strength of the…
NEW YORK (Reuters Health) – After catheter ablation, patients with obstructive sleep apnea (OSA) are more likely to experience recurrence of atrial fibrillation (AF) than are their OSA-free…
NEW YORK (Reuters Health) – Diabetes incidence falls during rosiglitazone treatment but returns to baseline after rosiglitazone withdrawal, according to the preprint version of a study that is…
